Design and optimization of a new series of HSP70 inhibitors for use in the treatment of pancreatic cancer.

被引：0
|
作者：
Maxwell, David S. [1 ]
Sun, Duoli [1 ]
Peng, Zhenghong [1 ]
Qi, Wei [1 ]
McConkey, David [1 ]
Abbruzzese, James L. [1 ]
Bornmann, William G. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B101
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Identification of new small molecules as dual FoxM1 and Hsp70 inhibitors using computational methods
    Alimardan, Zahra
    Abbasi, Maryam
    Khodarahmi, Ghadamali
    Kashfi, Khosrow
    Hasanzadeh, Farshid
    Aghaei, Mahmud
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2022, 17 (06) : 635 - 656
  • [42] Induction of Hsp70 in human breast cancer cells treated with Hsp90 inhibitors: a predictive marker and promising target for the tumor radiosensitization
    Kudryavtsev, V.
    Khokhlova, A.
    Mosina, V.
    Makarova, Y.
    Kabakov, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S116 - S116
  • [43] New HSP90 selective inhibitors as therapeutic agents for prostate and bladder cancer.
    Liu, Weiya
    Jensen, Derek
    Lee, Eugene
    Gills, Jessie
    Holzbeierlein, Jeffrey M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [44] Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
    Julia A. Yaglom
    Yongmei Wang
    Amy Li
    Zhenghu Li
    Stephano Monti
    Ilya Alexandrov
    Xiongbin Lu
    Michael Y. Sherman
    Scientific Reports, 8
  • [45] Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations
    Yaglom, Julia A.
    Wang, Yongmei
    Li, Amy
    Li, Zhenghu
    Monti, Stephano
    Alexandrov, Ilya
    Lu, Xiongbin
    Sherman, Michael Y.
    SCIENTIFIC REPORTS, 2018, 8
  • [46] Combined Treatment With HSP90 Inhibitors and HSP70 Inducers Ameliorates HCl-induced Chronic Lung Injury and Pulmonary Fibrosis in New Zealand White Rabbits
    Biancatelli, R. Colunga
    Solopov, P. A.
    Day, T.
    Catravas, J. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [47] Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer
    Xue, Ding
    Xu, Yibin
    Kyani, Armita
    Roy, Joyeeta
    Dai, Lipeng
    Sun, Duxin
    Neamati, Nouri
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 3404 - 3419
  • [48] A novel method to assay molecular chaperone activity of HSP70: Evaluation of drug resistance in cancer treatment
    Ding, Xiaorong
    Li, Hao
    Xie, Haona
    Huang, Yue
    Hou, Yafei
    Yin, Yongmei
    Li, Genxi
    BIOSENSORS & BIOELECTRONICS, 2013, 47 : 75 - 79
  • [49] Rectal cancer. Treatment optimization by (new)adjuvant therapy?
    Fasolini, F
    ZENTRALBLATT FUR CHIRURGIE, 1999, 124 (05): : 441 - 445
  • [50] Nuclear transporter HIKESHI is a novel independent poor overall survival for pancreatic cancer; targeting can inhibit pancreatic cancer growth via HSP70 suppression
    Erkhem-Ochir, Bilguun
    Yokobori, Takehiko
    Dorjkhorloo, Gendensuren
    Okami, Haruka
    Seki, Takaomi
    Harimoto, Norifumi
    Muranushi, Ryo
    Hoshino, Kouki
    Hagiwara, Kei
    Ishii, Norihiro
    Tsukagoshi, Mariko
    Araki, Kenichiro
    Saeki, Hiroshi
    Shirabe, Ken
    CANCER RESEARCH, 2024, 84 (07)
12345